Liver disease and heart failure: Back and forth
In their clinical practice, physicians can face heart diseases (chronic or acute heart failure)
affecting the liver and liver diseases affecting the heart. Systemic diseases can also affect …
affecting the liver and liver diseases affecting the heart. Systemic diseases can also affect …
Mechanism-based inhibition of CYP450: an indicator of drug-induced hepatotoxicity
S Feng, X He - Current drug metabolism, 2013 - ingentaconnect.com
Xenobiotics are converted by cytochrome P450 (CYP450) into highly reactive metabolites
(RMs) that covalently bind to the catalytic site of the enzyme itself, subsequently causing …
(RMs) that covalently bind to the catalytic site of the enzyme itself, subsequently causing …
Acute hepatotoxicity of intravenous amiodarone: case report and review of the literature
CC Chen, CC Wu - American journal of therapeutics, 2016 - journals.lww.com
Amiodarone is a class III antiarrhythmic drug widely used for the treatment of both
supraventricular and ventricular arrhythmias in intensive care unit. Hepatotoxicity of …
supraventricular and ventricular arrhythmias in intensive care unit. Hepatotoxicity of …
Hepatotoxicity of cardiovascular and antidiabetic drugs
D Halegoua-De Marzio, VJ Navarro - Drug-induced liver disease, 2013 - Elsevier
With the increasing prevalence of cardiovascular disease and associated disorders globally,
there has been a proliferation of medications for antiplatelet therapy, dyslipidemia, glycemic …
there has been a proliferation of medications for antiplatelet therapy, dyslipidemia, glycemic …
[HTML][HTML] Predictors of intravenous amiodarone induced liver injury
OA Diab, J Kamel, AA Abd-Elhamid - The Egyptian Heart Journal, 2017 - Elsevier
Background Intravenous (IV) amiodarone may be associated with liver injury that may
necessitate drug discontinuation. The prediction of amiodarone induced liver injury (AILI) …
necessitate drug discontinuation. The prediction of amiodarone induced liver injury (AILI) …
A facile cell-involved microfluidic platform for assessing risk of hepatotoxic chemicals via on-line monitoring of multi-indexes
W Lu, B Huang, Y He, J Yang, Y Li - Sensors and Actuators B: Chemical, 2021 - Elsevier
Toxicity assessment is necessary in many fields, but the common animal experiments and
traditional cell-based bioassays are endpoint tests and limited in the aspects of cost …
traditional cell-based bioassays are endpoint tests and limited in the aspects of cost …
[PDF][PDF] Severe acute hepatitis following intravenous amiodarone: a case report and review of the literature
A Stratton, J Fenderson, P Kenny, DL Helman - Acta gastro-enterologica …, 2015 - ageb.be
Abstract Background and Aims: Hepatotoxic complications of long-term oral amiodarone
therapy have been well described; however, liver injury secondary to parenteral infusion of …
therapy have been well described; however, liver injury secondary to parenteral infusion of …
胺碘酮致严重肝损害二例
范平， 周艳， 熊伟民 - 中华消化病与影像杂志: 电子版, 2013 - cqvip.com
胺碘酮为Ⅲ 类广谱抗心律失常药, 被广泛应用于临床治疗和预防各种室性,
室上性心律失常及心房颤动. 但在取得临床疗效的同时, 该药引起的肝脏损害亦较常见 …
室上性心律失常及心房颤动. 但在取得临床疗效的同时, 该药引起的肝脏损害亦较常见 …
[PDF][PDF] ФАКУЛТЕТ МЕДИЦИНСКИХ НАУКА УНИВЕРЗИТЕТ У КРАГУЈЕВЦУ
Ј Јовановић - medf.kg.ac.rs
Акутна хепатотоксичност је један од највећих проблема фармаковигиланце. Дијагноза
овог нежељеног дејства би требало да се заснива на клиничким критеријумима али и …
овог нежељеног дејства би требало да се заснива на клиничким критеријумима али и …